Imagion Biosystems has lodged Notice to Optionholders — Pro-Rata Non-Renounceable Rights Issue.
View the Notice to Optionholders.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance